Search results
Results from the WOW.Com Content Network
[citation needed] Also by then, "a wave of recalls" had taken place. [21] Some of the lawsuits, which by October 2021 included over 100,000 plaintiffs, [5] were filed due to impending statute of limitations laws; estimates of how many people used Zantac have been given as high as 15 million. [citation needed] Facets of the legal rangling included:
Sanofi has sold over-the-counter Zantac in the U.S. and Canada since 2017. It is pulling the drug off shelves after previous recalls by some manufacturers of generic versions of the drug.
In 2019, some manufacturers and pharmacies halted Zantac sales after NDMA was detected in some pills. Shortly afterwards, lawsuits began piling up from people who said they developed cancer after ...
Sanofi acquired Zantac in 2017. Before that, other companies owned the drug. Peter Pitts, the former associate commissioner of the FDA, says these types of lawsuits are concerning for the industry.
NEW YORK (Reuters) -Sanofi has reached an agreement in principle to settle 4,000 U.S. lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday. Sanofi did ...
In October 2019, Sanofi recalled all over-the-counter Zantac in the United States and Canada, [107] [108] [17] Perrigo issued a worldwide recall of ranitidine, [109] [17] Dr. Reddy's issued a recall of all ranitidine products in the United States, [110] [17] and Novitium Pharma recalled all ranitidine hydrochloride capsules in the US. [111] [17]
By Brendan Pierson (Reuters) -A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that ...
In 2019, some manufacturers and pharmacies halted Zantac sales over concerns that its active ingredient, ranitidine, degraded over time to form a chemical called NDMA. While NDMA can be present in ...